Syndax Pharmaceuticals Inc (SNDX) › Total AssetsSyndax Pharmaceuticals Inc (SNDX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2015: $89.90M2016: $109.01M2017: $137.19M2018: $83.94M2019: $63.52M2020: $300.61M2021: $449.66M2022: $497.24M2023: $612.88M2024: $724.82M2025: $529.71M$529.71M2015Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$529.71M-26.9%2024$724.82M+18.3%2023$612.88M+23.3%2022$497.24M+10.6%2021$449.66M+49.6%2020$300.61M+373.2%2019$63.52M-24.3%2018$83.94M-38.8%2017$137.19M+25.8%2016$109.01M+21.3%2015$89.90M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share